Literature DB >> 20419371

Direct imaging of viable myocardium by gated SPECT in patients with ischaemic left ventricular dysfunction.

Marco Spadafora1, Paola Varrella, Wanda Acampa, Marco Spirito, Carmela Nappi, Luigi Mansi, Paolo Miletto, Giuseppe Rosato, Alberto Cuocolo.   

Abstract

PURPOSE: The aim of the study was to evaluate a novel polar map of myocardial viability obtained by gated SPECT imaging to predict functional recovery after revascularization in patients with ischaemic left ventricular (LV) dysfunction.
METHODS: The study group comprised 17 patients (15 men, mean age 58 +/- 9 years) with ischaemic LV dysfunction (ejection fraction <or=40%) who underwent nitrate-enhanced gated SPECT before and 6 months after coronary revascularization. A parametric image of viable myocardium (VIA) was obtained using a semiautomated method to subtract the point-to-point motion polar map from the perfusion polar map. A parametric image of segments with functional recovery (REC) was obtained by subtracting the baseline motion polar map from the motion polar map after revascularization.
RESULTS: Of the total 340 segments, 248 (73%) were considered viable on the basis of the VIA map. After revascularization, of 248 dysfunctional viable segments 186 (75%) showed an improvement in LV function. An increase in LV ejection fraction (from 30 +/- 10% to 42 +/- 11%, p < 0.01) and a decrease in end-diastolic volume (from 207 +/- 74 ml to 174 +/- 74 ml, p < 0.01) were observed after revascularization. Overall concordance between the VIA map and the REC map was 85%, with a k value of 0.63. Sensitivity, specificity, and positive and negative predictive values of the VIA map for predicting functional recovery were 89%, 75%, 91% and 71%, respectively.
CONCLUSION: The proposed polar map of myocardial viability obtained by gated SPECT imaging accurately predicts functional recovery after coronary revascularization. Thus, a direct quantitative image of viability obtained from perfusion/function matching may be helpful for clinical decision-making in patients with ischaemic LV dysfunction.

Entities:  

Mesh:

Year:  2010        PMID: 20419371     DOI: 10.1007/s00259-010-1463-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  16 in total

1.  Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium.

Authors:  J J Bax; D Poldermans; A Elhendy; E Boersma; S H Rahimtoola
Journal:  Curr Probl Cardiol       Date:  2001-02       Impact factor: 5.200

2.  Guidelines for the diagnosis and treatment of chronic heart failure.

Authors:  W J Remme; K Swedberg
Journal:  Eur Heart J       Date:  2001-09       Impact factor: 29.983

Review 3.  Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use? A critical appraisal.

Authors:  Jeroen J Bax; Gerardo Ansalone; Ole A Breithardt; Genevieve Derumeaux; Christophe Leclercq; Martin J Schalij; Peter Sogaard; Martin St John Sutton; Petros Nihoyannopoulos
Journal:  J Am Coll Cardiol       Date:  2004-07-07       Impact factor: 24.094

4.  Identification of viable myocardium in patients with chronic coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutyl isonitrile.

Authors:  A Cuocolo; L Pace; B Ricciardelli; M Chiariello; B Trimarco; M Salvatore
Journal:  J Nucl Med       Date:  1992-04       Impact factor: 10.057

5.  Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis.

Authors:  Kevin C Allman; Leslee J Shaw; Rory Hachamovitch; James E Udelson
Journal:  J Am Coll Cardiol       Date:  2002-04-03       Impact factor: 24.094

6.  Influence of the assessment of defect severity and intravenous nitrate administration during tracer injection on the detection of viable hibernating myocardium with data-based quantitative technetium 99m-labeled sestamibi single-photon emission computed tomography.

Authors:  R Sciagrà; G Bisi; G M Santoro; M Agnolucci; O Zoccarato; P F Fazzini
Journal:  J Nucl Cardiol       Date:  1996 May-Jun       Impact factor: 5.952

7.  Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in chronic coronary artery disease.

Authors:  S Maurea; A Cuocolo; A Soricelli; L Castelli; A Nappi; F Squame; M Imbriaco; B Trimarco; M Salvatore
Journal:  J Nucl Med       Date:  1995-11       Impact factor: 10.057

8.  Nitrates improve detection of ischemic but viable myocardium by thallium-201 reinjection SPECT.

Authors:  Z X He; J Darcourt; A Guignier; E Ferrari; F Bussière; M Baudouy; P Morand
Journal:  J Nucl Med       Date:  1993-09       Impact factor: 10.057

Review 9.  Assessing myocardial viability to help select patients for revascularization to improve left ventricular dysfunction due to coronary artery disease.

Authors:  R E Patterson; W C Pilcher
Journal:  Semin Thorac Cardiovasc Surg       Date:  1995-10

10.  Incremental prognostic value of cardiac single-photon emission computed tomography after nitrate administration in patients with ischemic left ventricular dysfunction.

Authors:  Laura Evangelista; Wanda Acampa; Mario Petretta; Adele Ferro; Francesca Ricci; Luca Luongo; Stefania Daniele; Giorgio Punzo; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2009-01-20       Impact factor: 5.952

View more
  1 in total

1.  Myocardial viability: what we knew and what is new.

Authors:  Adel Shabana; Ayman El-Menyar
Journal:  Cardiol Res Pract       Date:  2012-09-05       Impact factor: 1.866

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.